Want to see AIDX full AI Analyst Report?
20/20 Biolabs, Inc. (AIDX) Financial Statements
20/20 Biolabs, Inc. Financial Overview
20/20 Biolabs, Inc.'s market cap is currently $2.85M. The company's EPS TTM is $-0.76; its P/E ratio is -0.28; 20/20 Biolabs, Inc. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Mar 26 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 2.05M | $ 1.75M | $ 1.42M | $ 11.06M | $ 9.62M |
| Gross Profit | $ 604.54K | $ 360.31K | $ 109.14K | $ 5.12M | $ 4.69M |
| Operating Income | $ -3.33M | $ -5.66M | $ -6.36M | $ 1.68M | $ 1.94M |
| EBITDA | $ -3.50M | $ -5.53M | $ -6.19M | $ 1.97M | $ 2.07M |
| Net Income | $ -3.74M | $ -5.55M | $ -6.39M | $ 2.19M | $ 2.07M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 1.03B | $ 1.78M | $ 4.09M | $ 8.81M | $ 3.35M |
| Total Assets | $ 4.14M | $ 3.61M | $ 6.37M | $ 12.22M | $ 10.27M |
| Total Debt | $ 1.28B | $ 1.51M | $ 2.07M | $ 2.41M | $ 2.35M |
| Net Debt | $ 258.04M | $ -270.61K | $ -2.02M | $ -6.39M | $ -1.00M |
| Total Liabilities | $ 4.16M | $ 2.08M | $ 2.08M | $ 2.84M | $ 3.38M |
| Stockholders' Equity | $ -19.23K | $ 1.53M | $ 4.29M | $ 9.37M | $ 6.89M |
| Cash Flow | |||||
| Free Cash Flow | $ -1.92B | $ -2.60M | $ -4.64M | $ 5.54M | $ -1.30M |
| Operating Cash Flow | $ -1.92B | $ -2.60M | $ -4.63M | $ 5.80M | $ -1.07M |
| Investing Cash Flow | $ 0.00 | $ 0.00 | $ -43.76K | $ -462.55K | $ -228.15K |
| Financing Cash Flow | $ 1.16B | $ 293.33K | $ -45.99K | $ 112.60K | $ 1.19M |
Currency in USD